Inhibition of in vitro Ebola infection by anti-parasitic quinoline derivatives [version 1; peer review: 2 approved]
There continues to be no approved drugs for the treatment of Ebola virus disease (EVD). Despite a number of candidate drugs showing limited efficacy in vitro and/or in non-human primate studies, EVD continues to plaque certain areas of Africa without any efficacious treatments yet available. Recentl...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
F1000 Research Ltd
2020-04-01
|
| Series: | F1000Research |
| Online Access: | https://f1000research.com/articles/9-268/v1 |